Results 151 to 160 of about 1,780 (186)
Some of the next articles are maybe not open access.

Contractile effects of 8-hydroxy-2-(di-n-propylamino) tetralin and flesinoxan in human isolated basilar artery

European Journal of Pharmacology, 1991
The aim of the present study was to assess the effects of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and flesinoxan in ring preparations of human basilar artery. 5-Hydroxytryptamine-(5-HT), 8-OH-DPAT and flesinoxan induced concentration-dependent contractions of human basilar artery, the rank order of agonist potency
A A, Parsons   +2 more
openaire   +2 more sources

Determination of brain concentrations of 8-hydroxy-2-(DI-n-propylamino)tetralin by liquid chromatography with electrochemical detection

Biochemical Pharmacology, 1989
A liquid chromatographic method using electrochemical detection is described for the assay of brain concentrations of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), centrally acting serotonin agonists selective for the 5HT-1A subtype of serotonin receptors. The method is sensitive to approximately 5 ng/g concentrations. After a 1mg/kg s.c. dose of
K W, Perry, R W, Fuller
openaire   +2 more sources

Gonadotropin and prolactin secretion in prepubertal female rats treated with 8-hydroxy-2-(di-n-propylamino) tetralin

Journal of Neural Transmission, 1993
The effect of serotoninergic activation on gonadotropin and prolactin release were analysed in 16-day-old intact female rats. In the first experiment, females were decapitated 30 min after i.p. administration of 100 mg/kg of 5-hydroxytryptophan (5-HTP) or vehicle; in the second experiment the rats were decapitated 15 and 30 min after i.p.
E, Aguilar   +3 more
openaire   +2 more sources

Nicotine and its withdrawal modify dorsal raphe 8-hydroxy-2-(di-n-propylamino) tetralin feeding

Pharmacology Biochemistry and Behavior, 2003
Nicotine (NIC) and its withdrawal modify dorsal raphe (DR) serotonin (5-HT) neurotransmission in ways that may contribute to the body weight loss vs. gain associated with cigarette smoking vs. cessation, respectively. Modifications in feeding to DR infusions of the 5-HT-1A receptor agonist, 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), were used
Christopher, Bishop   +2 more
openaire   +2 more sources

Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin

Journal of Medicinal Chemistry, 1988
Aromatic ortho-hydroxylation in the liver might be one of several possible reasons for the low bioavailabilities of the potent, centrally acting dopaminergic and serotoninergic agonists 5- and 8-hydroxy-2-(di-n-propylamino)tetralin, respectively. In vitro and in vivo experiments showed that such an oxidative metabolism did indeed take place.
H, Wikström   +6 more
openaire   +2 more sources

Sex differences in neurochemical and behavioral effects of 8-hydroxy-2-(DI-n-propylamino) tetralin

Life Sciences, 1992
A number of neurochemical investigations have shown that 5-hydroxytryptamine (5-HT) metabolism and turnover is greater in females than male rats. However increased 5-HT metabolism does not necessarily imply greater 5-HT release at the functional post-synaptic sites. Pharmacological research based on 5-HT receptor stimulation therefore gained attention.
openaire   +2 more sources

Potential antidepressant properties of 8-hydroxy-2-(di-n-propylamino) tetralin, a selective serotonin1A receptor agonist

European Journal of Pharmacology, 1987
8-Hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), a selective serotonin1A receptor agonist, was studied for its anti-immobility activity in the forced swimming test after different schedules of treatment. Single doses of 0.250 and 0.500 mg/kg 8-OH-DPAT s.c. reduced the immobility time of rats with no effect on open-field activity.
L, Cervo, R, Samanin
openaire   +2 more sources

Antiemetic effects of flesinoxan in cats: comparisons with 8-hydroxy-2-(di-n-propylamino)tetralin

European Journal of Pharmacology, 1994
The antiemetic effects of flesinoxan were evaluated following s.c. administration in cats. Flesinoxan produced a dose-dependent suppression of motion sickness and also reduced xylazine-induced emesis at higher doses. Flesinoxan had a short latency to onset and may have a brief duration of action.
openaire   +2 more sources

Potential anxiolytic properties of 8-hydroxy-2-(Di-N-propylamino)tetralin, a selective serotonin1A receptor agonist

Psychopharmacology, 1988
The effects of a selective serotonin 1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT), were studied in two animal models of anxiety. Peripherally injected 8-OH-DPAT in doses ranging from 0.125 to 2.0 mg/kg did not increase black-white transitions (BWT) and black square entries (BSE) in a two-compartment exploratory test or ...
M, Carli, R, Samanin
openaire   +2 more sources

Metabolism of [propyl-3H]-8-hydroxy-2-(N,N-di-n-propylamino)tetralin in rat

Xenobiotica, 1995
1. Male Sprague-Dawley rats given (RS)-[3H]-8-OHDPAT by intraperitoneal (i.p.) or intravenous (i.v.) injection, or orally (p.o.) by gavage, excreted the majority of the dose in the urine (> 80% in 3 days and > 70% in the first 24 h). A smaller proportion of the dose was excreted in the faeces (> 10% in 3 days), mostly in the first 24 h.
J P, Mason, J, Caldwell, L G, Dring
openaire   +2 more sources

Home - About - Disclaimer - Privacy